Developer docs
API playgroundTry for free, no card

Search company profiles

Bioengineering department, Stanford University

Full company profile

uuid003zkx8

Namestring
Bioengineering department, Stanford University
Legal namestring
Stanford University
Company typeenum
Private
Founded yearint
2002
Descriptiontext

Stanford Bioengineering is an academic department of Stanford University founded in 2002 as a joint unit of the School of Engineering and the School of Medicine, focused on combining life sciences and engineering across synthetic biology, gene editing, AI/machine learning for biology, bioimaging, protein engineering, microbiome research, biomechanics, bioprinting, and molecular diagnostics. It operates more than 30 faculty-run labs and serves undergraduate students (BS Bioengineering, BS Biomedical Computation), coterminal MS candidates, graduate students (PhD, Master's, MD Scholarly Concentration, dual and joint programs), and postdoctoral scholars. The department's business model is academic: it generates revenue through university tuition and fees, sponsored research from federal agencies (NIH, NSF, DoD) and foundations (Gates, Vannevar Bush), licensing royalties on proprietary technologies, philanthropic gifts, and executive education via Stanford Biodesign.

The department's core research outputs span hardware platforms, biological tools, and computational methods. Notable proprietary technologies include the Foldscope paper microscope (reaching over 2 million users globally and licensed to Foldscope Inc.), The Squid open-source confocal microscope (licensed to Cephla), the Gravity Machine virtual-reality microscope, CRISPR/Cas9 and RNA-editing platforms from Stanley Qi's lab, AI-driven proteome mapping from Emma Lundberg's lab, cell-free protein synthesis platforms from Michael Jewett's lab, fungal fermentation platforms from the Hill-Maini Lab, and a 3D bioprinting effort aimed at implanting a human heart. Outreach and educational products include the LABraries initiative (with MIT Media Lab), CRISPR education kits for high school classrooms, and Clubes de Ciencia Mexico (15,000+ students across 8 countries).

The department's go-to-market motion is community-led and event-driven: it recruits students through academic admissions, faculty through coordinated joint searches (notably with the Arc Institute in 2025), and industry/clinical partners through Stanford-Coulter Translational Research Grants, Stanford Biodesign programs, corporate partnerships, and alumni networks. Recent strategic moves include the 2025 Arc Institute joint faculty search, the 2025 Chef-in-Residence Program with Mugaritz and the Doerr School of Sustainability, the 2026 deep-sea research partnership with Schmidt Ocean Institute, and the appointment of Markus Covert as the new department Chair. Faculty have received NIH Pioneer Awards, the National Medal of Technology and Innovation, Vannevar Bush Faculty Fellowships, Rhodes Scholarships, and other recognitions, and the department has trained 242 faculty worldwide and awarded 616+ degrees since founding.

Short descriptiontext

Stanford Bioengineering is an academic department jointly housed in the School of Engineering and School of Medicine, conducting interdisciplinary research in synthetic biology, gene editing, AI, bioimaging, and bioprinting across 30+ faculty labs, while serving undergraduate, graduate, and postdoctoral students through degree programs and translational partnerships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersStanford, United States
HQ citystring
Stanford
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bioengineering research, biomedical education, synthetic biology, CRISPR gene editing, translational research
Industry4 codes
1Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development)
CodeHLAAAIADPrimaryYes
2Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
CodeHLAGAIAFPrimaryNo
3Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization)
CodeHLAAAIACPrimaryNo
4Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling)
CodeHLAAAJAFPrimaryNo
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Laboratory Analytical Instruments3826
Product category
Higher Education - Bioengineering Research and Training
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Academic Tuition and Fees
TypeSubscription Recurring
Description

As a Stanford University academic department, Bioengineering generates revenue through undergraduate and graduate tuition, coterminal program fees, and graduate application fees ([email protected]). Revenue supports faculty positions, teaching labs, and facilities.

bioengineering.stanford.edu
2Sponsored Research and Grants
TypeProfessional Services
Description

Department faculty and researchers generate significant research funding through federal agencies (NIH, NSF, DoD), foundations (Vannevar Bush Fellowship, Gates Foundation), and industry sponsors. The Stanford-Coulter Translational Research Grants Program provides internal funding for translational projects.

bioengineering.stanford.edu
3Licensing and Technology Transfer
TypeLicensing Royalties
Description

Technologies developed in the department are commercialized through licensing agreements. The Squid microscope is licensed to Cephla; Foldscope is commercialized through Foldscope Inc. Revenue supports further research and development.

bioengineering.stanford.edu
4Gifts and Philanthropic Donations
TypeAffiliate Referral
Description

The department solicits charitable contributions through the 'Give' channel on its website (bioengineering.stanford.edu/get-involved/give), supporting fellowships, research initiatives, and community programs.

bioengineering.stanford.edu
5Executive Education and Professional Programs
TypeProfessional Services
Description

Stanford Biodesign programs and professional education offerings generate revenue through participant fees for innovation fellowships and executive training in health technology.

bioengineering.stanford.edu
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Operations, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Stanford Bioengineering is an interdisciplinary academic department jointly housed between the Stanford School of Engineering and School of Medicine, offering undergraduate, coterminal, master's, PhD, and MD-affiliated degree programs alongside postdoctoral training. The department operates 30+ faculty-led research labs producing technologies in synthetic biology, CRISPR gene editing, AI-driven proteomics, bioimaging, cell-free protein synthesis, 3D bioprinting, and sustainable food systems. Outputs include commercialized open-source tools (Foldscope 2.0, The Squid), translational research via Stanford Biodesign, and community biology initiatives (LABraries, Foldscope distribution).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 616+ degrees awarded and 242 faculty trained worldwide since founding in 2002
+4 more records
Product overview1 text field

Stanford Bioengineering is an academic department offering educational programs (undergraduate, graduate, PhD) and conducting research across multiple specialized areas. Key products include The Squid (open-source confocal microscope), The Gravity Machine (virtual reality microscope for microbes), and Foldscope 2.0 (paper microscope). The department operates the Stanford Synthetic Biology initiative and runs the Chef-in-Residence Program for food sustainability research. Research outputs include CRISPR education kits and the ColoTech pro-diagnostic for colorectal cancer detection.

Product and service8 records
1BS Bioengineering Degree Program
CategoryUndergraduate Degree Program
2BS Biomedical Computation Degree Program
CategoryUndergraduate Degree Program
3Coterminal MS Program
CategoryGraduate Degree Program
4PhD Program in Bioengineering
CategoryDoctoral Degree Program
5Master's Program in Bioengineering
CategoryGraduate Degree Program
6MD Scholarly Concentration in Bioengineering
CategoryMedical Scholarly Concentration
7Stanford Biodesign Innovation Fellowship
CategoryProfessional Fellowship Program
8Foldscope 2.0
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership15 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Research partnership through R/V Falkor (too) enabling the Prakash Lab's deep-sea expedition that discovered 31+ new species. Schmidt Ocean Institute provides research vessel infrastructure, ROV SuBastian, and operational support for at-sea research. The expedition deployed The Squid and Gravity Machine imaging tools aboard the vessel.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2026-01-01
Description

Cephla licensed The Squid open-source confocal microscope from the Prakash Lab for commercialization. This brings the lab's imaging technology to market for broader scientific and research use beyond academic settings.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Stanford Bioengineering and the Arc Institute launched a coordinated joint faculty search, combining recruitment efforts to attract top faculty talent in bioengineering. This represents a strategic alignment between the department and the Arc Institute's mission in long-term multidisciplinary research.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Two-Michelin-star restaurant Mugaritz in Spain's Basque Country, led by Ramon Perisé Moré, is the inaugural Chef-in-Residence at the Hill-Maini Lab. The collaboration explores the intersection of gastronomy, sustainability, and bioengineering through fungi-based food innovation, bridging culinary arts and scientific research.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Stanford's Doerr School of Sustainability co-sponsored the Chef-in-Residence Program with the Bioengineering Department and Hill-Maini Lab, reflecting interdisciplinary collaboration between sustainability and food systems bioengineering.

6Stanford Office of the Vice President for the Arts
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Stanford's VP for the Arts office co-sponsored the Chef-in-Residence Program, integrating artistic and creative disciplines with bioengineering research in sustainable food systems.

bioengineering.stanford.edu
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Stanford and MIT scholars collaborated on the LABraries initiative, proposing a national network of public biology labs. Dr. David Sun Kong of MIT Media Lab co-led the project with Stanford researchers including Drew Endy and Callie Chappell. The initiative draws inspiration from public libraries to democratize biology access.

8U.S. White House Office of Science and Technology Policy (OSTP)
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Dr. Gerald Epstein, former Assistant Director for Biosecurity and Emerging Technologies at OSTP, consulted on the LABraries initiative, providing biosecurity expertise and federal government perspective on public biology lab policy.

bioengineering.stanford.edu
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2025-01-01
Description

Foldscope Inc. commercializes the Foldscope paper microscope invented at Stanford by Manu Prakash and Jim Cybulski. The company distributes Foldscope and Foldscope 2.0 globally, enabling the democratization of microscopy access through a network of consumer and educational buyers.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Biodesign NEXT provided support to the ColoTech capstone team beyond the classroom, advancing both technical development and commercialization aspects of the early colorectal cancer detection project that won the DEBUT 2024 NCI Cancer Prize.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Stanford Medicine and Northpond Ventures launched Northpond Laboratories, with Markus Covert serving as Stanford Bioengineering's faculty lead. The partnership supports biomedical research infrastructure and innovation.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

Chan Zuckerberg Biohub partnered with Berkeley-Stanford-UCSF Next Generation Faculty Symposium to showcase rising stars in bioengineering and biomedical sciences. CZ Biohub co-sponsored the virtual symposium as part of the Berkeley-Stanford-UCSF collaboration.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

Stanford EST Hub supports the Bio Futures Fellows Program along with the Bio Policy & Leadership at Stanford (Bio.Polis) Initiative and the Department of Bioengineering, funding interdisciplinary fellowships at the intersection of biotechnology, ethics, and public policy.

Strategic tierFlagshipTypeChannel Partner/ Reseller/ DistributorAnnounced on2017-01-01
Description

US-based organization co-founded by Rogelio Hernández-López that implements the Clubes de Ciencia program across 8 countries, expanding international reach of the STEM outreach initiative.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2014-01-01
Description

STEM outreach program co-founded by Rogelio Hernández-López that delivers hands-on workshops to high school and college students across Iberoamerica. The program has served over 15,000 students across 8 countries, with graduate students and postdocs designing and delivering curriculum annually.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Caltech's Department of Bioengineering with strengths in bioimaging, synthetic biology, and molecular biophysics. Comparable small-elite department model with similar faculty-to-student ratios and research output.

TypeDirect peer
Description

Harvard-affiliated bioengineering research institute with strong translational mandate and high-profile faculty. Comparable in impact-driven bioengineering research model and licensing output.

TypeDirect peer
Description

Joint biomedical engineering program combining Georgia Tech engineering strengths with Emory medical school clinical access. Comparable large-scale BME program competing for translational grants and industry partnerships.

TypeDirect peer
Description

Bay Area biomedical research institute that has co-sponsored Next Generation Faculty Symposium with Stanford and Berkeley. Comparable in mission to accelerate bioengineering research and technology development.

TypeDirect peer
Description

MIT's flagship bioengineering department offering BS, MS, and PhD programs with parallel synthetic biology, bioimaging, and translational research strengths. Closest structural analog to Stanford BioE among peer institutions and direct competitor for top graduate students and faculty.

TypeDirect peer
Description

Joint department between Berkeley College of Engineering and School of Medicine with parallel synthetic biology and computational bioengineering research. Already co-hosts the Stanford-Berkeley-UCSF Next Generation Faculty Symposium and partners on multiple joint programs.

TypeDirect peer
Description

Stanford-adjacent independent research institute with parallel faculty search efforts. Competes for the same pool of bioengineering talent and operates with overlapping synthetic biology and genomics research priorities.

TypeDirect peer
Description

One of the oldest and largest US biomedical engineering programs, jointly housed across engineering and medicine schools. Comparable in scale, translational funding, and medical-device innovation pipeline.

TypeDirect peer
Description

Duke's Pratt School of Engineering BME department with parallel medical-school integration and translational focus. Competes for graduate students and federal research funding in adjacent therapeutic areas.

TypeDirect peer
Description

UCSF bioengineering program with medical-school-anchored translational focus. Co-participates in joint faculty search initiatives with Stanford and recruits from overlapping applicant pools.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability10 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature11 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bioengineering department, Stanford University

Higher Education - Bioengineering Research and Trainingbioengineering.stanford.edu

Stanford Bioengineering is an academic department jointly housed in the School of Engineering and School of Medicine, conducting interdisciplinary research in synthetic biology, gene editing, AI, bioimaging, and bioprinting across 30+ faculty labs, while serving undergraduate, graduate, and postdoctoral students through degree programs and translational partnerships.

What Bioengineering department, Stanford University does

Stanford Bioengineering is an academic department of Stanford University founded in 2002 as a joint unit of the School of Engineering and the School of Medicine, focused on combining life sciences and engineering across synthetic biology, gene editing, AI/machine learning for biology, bioimaging, protein engineering, microbiome research, biomechanics, bioprinting, and molecular diagnostics. It operates more than 30 faculty-run labs and serves undergraduate students (BS Bioengineering, BS Biomedical Computation), coterminal MS candidates, graduate students (PhD, Master's, MD Scholarly Concentration, dual and joint programs), and postdoctoral scholars. The department's business model is academic: it generates revenue through university tuition and fees, sponsored research from federal agencies (NIH, NSF, DoD) and foundations (Gates, Vannevar Bush), licensing royalties on proprietary technologies, philanthropic gifts, and executive education via Stanford Biodesign.

The department's core research outputs span hardware platforms, biological tools, and computational methods. Notable proprietary technologies include the Foldscope paper microscope (reaching over 2 million users globally and licensed to Foldscope Inc.), The Squid open-source confocal microscope (licensed to Cephla), the Gravity Machine virtual-reality microscope, CRISPR/Cas9 and RNA-editing platforms from Stanley Qi's lab, AI-driven proteome mapping from Emma Lundberg's lab, cell-free protein synthesis platforms from Michael Jewett's lab, fungal fermentation platforms from the Hill-Maini Lab, and a 3D bioprinting effort aimed at implanting a human heart. Outreach and educational products include the LABraries initiative (with MIT Media Lab), CRISPR education kits for high school classrooms, and Clubes de Ciencia Mexico (15,000+ students across 8 countries).

The department's go-to-market motion is community-led and event-driven: it recruits students through academic admissions, faculty through coordinated joint searches (notably with the Arc Institute in 2025), and industry/clinical partners through Stanford-Coulter Translational Research Grants, Stanford Biodesign programs, corporate partnerships, and alumni networks. Recent strategic moves include the 2025 Arc Institute joint faculty search, the 2025 Chef-in-Residence Program with Mugaritz and the Doerr School of Sustainability, the 2026 deep-sea research partnership with Schmidt Ocean Institute, and the appointment of Markus Covert as the new department Chair. Faculty have received NIH Pioneer Awards, the National Medal of Technology and Innovation, Vannevar Bush Faculty Fellowships, Rhodes Scholarships, and other recognitions, and the department has trained 242 faculty worldwide and awarded 616+ degrees since founding.

Bioengineering department, Stanford University firmographics

Firmographics
Name
Bioengineering department, Stanford University
Legal name
Stanford University
Website
https://bioengineering.stanford.edu
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
1–10 employees
Short description
Stanford Bioengineering is an academic department jointly housed in the School of Engineering and School of Medicine, conducting interdisciplinary research in synthetic biology, gene editing, AI, bioimaging, and bioprinting across 30+ faculty labs, while serving undergraduate, graduate, and postdoctoral students through degree programs and translational partnerships.
Ownership category
akta.pro rank

Bioengineering department, Stanford University industry classification

Industry
Product category
Higher Education - Bioengineering Research and Training
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Commercial Physical & Biological Research (8731), Laboratory Analytical Instruments (3826)
akta.pro primary industry
Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development) (HLAAAIAD)
akta.pro secondary industries
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF), Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization) (HLAAAIAC), Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling) (HLAAAJAF)

Keywords

  • Bioengineering research
  • Biomedical education
  • Synthetic biology
  • CRISPR gene editing
  • Translational research

Where Bioengineering department, Stanford University is headquartered

Location

Headquarters

HQ city
Stanford
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Bioengineering department, Stanford University business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Infrastructure, Operations, Others

Revenue model

  1. Academic Tuition and Fees: As a Stanford University academic department, Bioengineering generates revenue through undergraduate and graduate tuition, coterminal program fees, and graduate application fees ([email protected]). Revenue supports faculty positions, teaching labs, and facilities.
  2. Sponsored Research and Grants: Department faculty and researchers generate significant research funding through federal agencies (NIH, NSF, DoD), foundations (Vannevar Bush Fellowship, Gates Foundation), and industry sponsors. The Stanford-Coulter Translational Research Grants Program provides internal funding for translational projects.
  3. Licensing and Technology Transfer: Technologies developed in the department are commercialized through licensing agreements. The Squid microscope is licensed to Cephla; Foldscope is commercialized through Foldscope Inc. Revenue supports further research and development.
  4. Gifts and Philanthropic Donations: The department solicits charitable contributions through the 'Give' channel on its website (bioengineering.stanford.edu/get-involved/give), supporting fellowships, research initiatives, and community programs.
  5. Executive Education and Professional Programs: Stanford Biodesign programs and professional education offerings generate revenue through participant fees for innovation fellowships and executive training in health technology.

Go-to-market motion2 records

Distribution channels6 records

Marketing channels8 records

Bioengineering department, Stanford University product offering

Product offering

Core offering

Stanford Bioengineering is an interdisciplinary academic department jointly housed between the Stanford School of Engineering and School of Medicine, offering undergraduate, coterminal, master's, PhD, and MD-affiliated degree programs alongside postdoctoral training. The department operates 30+ faculty-led research labs producing technologies in synthetic biology, CRISPR gene editing, AI-driven proteomics, bioimaging, cell-free protein synthesis, 3D bioprinting, and sustainable food systems. Outputs include commercialized open-source tools (Foldscope 2.0, The Squid), translational research via Stanford Biodesign, and community biology initiatives (LABraries, Foldscope distribution).

Product overview

Stanford Bioengineering is an academic department offering educational programs (undergraduate, graduate, PhD) and conducting research across multiple specialized areas. Key products include The Squid (open-source confocal microscope), The Gravity Machine (virtual reality microscope for microbes), and Foldscope 2.0 (paper microscope). The department operates the Stanford Synthetic Biology initiative and runs the Chef-in-Residence Program for food sustainability research. Research outputs include CRISPR education kits and the ColoTech pro-diagnostic for colorectal cancer detection.

Differentiator

Problem solved

Functional benefit

Products and services

  • BS Bioengineering Degree Program
  • BS Biomedical Computation Degree Program
  • Coterminal MS Program
  • PhD Program in Bioengineering
  • Master's Program in Bioengineering
  • MD Scholarly Concentration in Bioengineering
  • Stanford Biodesign Innovation Fellowship
  • Foldscope 2.0

Quantifiable outcome

  • 616+ degrees awarded and 242 faculty trained worldwide since founding in 2002
  • +4 more outcomes

Companies that use Bioengineering department, Stanford University

Customer profile

Named customers7 records

Segments5 records

Ideal customer profiles4 records

Bioengineering department, Stanford University technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability10 records

Feature11 records

Bioengineering department, Stanford University partnerships and signals

Strategic signal

Partnerships

15 partnerships are on record, tiered core and flagship.

  • Schmidt Ocean InstitutecoreStrategic or Co-development Partner · 1 January 2026Research partnership through R/V Falkor (too) enabling the Prakash Lab's deep-sea expedition that discovered 31+ new species. Schmidt Ocean Institute provides research vessel infrastructure, ROV SuBastian, and operational support for at-sea research. The expedition deployed The Squid and Gravity Machine imaging tools aboard the vessel.
  • CephlacoreOEM/ Whitelabel/ Licensing Partner · 1 January 2026Cephla licensed The Squid open-source confocal microscope from the Prakash Lab for commercialization. This brings the lab's imaging technology to market for broader scientific and research use beyond academic settings.
  • Arc InstituteflagshipStrategic or Co-development Partner · 1 January 2025Stanford Bioengineering and the Arc Institute launched a coordinated joint faculty search, combining recruitment efforts to attract top faculty talent in bioengineering. This represents a strategic alignment between the department and the Arc Institute's mission in long-term multidisciplinary research.
  • MugaritzflagshipStrategic or Co-development Partner · 1 January 2025Two-Michelin-star restaurant Mugaritz in Spain's Basque Country, led by Ramon Perisé Moré, is the inaugural Chef-in-Residence at the Hill-Maini Lab. The collaboration explores the intersection of gastronomy, sustainability, and bioengineering through fungi-based food innovation, bridging culinary arts and scientific research.
  • Doerr School of SustainabilityflagshipStrategic or Co-development Partner · 1 January 2025Stanford's Doerr School of Sustainability co-sponsored the Chef-in-Residence Program with the Bioengineering Department and Hill-Maini Lab, reflecting interdisciplinary collaboration between sustainability and food systems bioengineering.
  • Stanford Office of the Vice President for the ArtsflagshipStrategic or Co-development Partner · 1 January 2025Stanford's VP for the Arts office co-sponsored the Chef-in-Residence Program, integrating artistic and creative disciplines with bioengineering research in sustainable food systems.
  • MIT Media Lab (Community Biotechnology Initiative)coreStrategic or Co-development Partner · 1 January 2025Stanford and MIT scholars collaborated on the LABraries initiative, proposing a national network of public biology labs. Dr. David Sun Kong of MIT Media Lab co-led the project with Stanford researchers including Drew Endy and Callie Chappell. The initiative draws inspiration from public libraries to democratize biology access.
  • U.S. White House Office of Science and Technology Policy (OSTP)flagshipStrategic or Co-development Partner · 1 January 2025Dr. Gerald Epstein, former Assistant Director for Biosecurity and Emerging Technologies at OSTP, consulted on the LABraries initiative, providing biosecurity expertise and federal government perspective on public biology lab policy.
  • Foldscope Inc.coreOEM/ Whitelabel/ Licensing Partner · 1 January 2025Foldscope Inc. commercializes the Foldscope paper microscope invented at Stanford by Manu Prakash and Jim Cybulski. The company distributes Foldscope and Foldscope 2.0 globally, enabling the democratization of microscopy access through a network of consumer and educational buyers.
  • Biodesign NEXTcoreStrategic or Co-development Partner · 1 January 2024Biodesign NEXT provided support to the ColoTech capstone team beyond the classroom, advancing both technical development and commercialization aspects of the early colorectal cancer detection project that won the DEBUT 2024 NCI Cancer Prize.
  • Northpond Ventures / Northpond LaboratoriescoreStrategic or Co-development Partner · 1 January 2023Stanford Medicine and Northpond Ventures launched Northpond Laboratories, with Markus Covert serving as Stanford Bioengineering's faculty lead. The partnership supports biomedical research infrastructure and innovation.
  • Chan Zuckerberg BiohubcoreStrategic or Co-development Partner · 1 January 2020Chan Zuckerberg Biohub partnered with Berkeley-Stanford-UCSF Next Generation Faculty Symposium to showcase rising stars in bioengineering and biomedical sciences. CZ Biohub co-sponsored the virtual symposium as part of the Berkeley-Stanford-UCSF collaboration.
  • Stanford Ethics, Society, and Technology (EST) HubcoreStrategic or Co-development Partner · 1 January 2020Stanford EST Hub supports the Bio Futures Fellows Program along with the Bio Policy & Leadership at Stanford (Bio.Polis) Initiative and the Department of Bioengineering, funding interdisciplinary fellowships at the intersection of biotechnology, ethics, and public policy.
  • Science Clubs International (SCI)flagshipChannel Partner/ Reseller/ Distributor · 1 January 2017US-based organization co-founded by Rogelio Hernández-López that implements the Clubes de Ciencia program across 8 countries, expanding international reach of the STEM outreach initiative.
  • Clubes de Ciencia MexicoflagshipStrategic or Co-development Partner · 1 January 2014STEM outreach program co-founded by Rogelio Hernández-López that delivers hands-on workshops to high school and college students across Iberoamerica. The program has served over 15,000 students across 8 countries, with graduate students and postdocs designing and delivering curriculum annually.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Bioengineering department, Stanford University competitors and assessment

Company assessment

Direct peers

  • Caltech Bioengineering: Caltech's Department of Bioengineering with strengths in bioimaging, synthetic biology, and molecular biophysics. Comparable small-elite department model with similar faculty-to-student ratios and research output.
  • Wyss Institute for Biologically Inspired Engineering: Harvard-affiliated bioengineering research institute with strong translational mandate and high-profile faculty. Comparable in impact-driven bioengineering research model and licensing output.
  • Georgia Tech / Emory Biomedical Engineering: Joint biomedical engineering program combining Georgia Tech engineering strengths with Emory medical school clinical access. Comparable large-scale BME program competing for translational grants and industry partnerships.
  • Chan Zuckerberg Biohub: Bay Area biomedical research institute that has co-sponsored Next Generation Faculty Symposium with Stanford and Berkeley. Comparable in mission to accelerate bioengineering research and technology development.
  • MIT Department of Biological Engineering: MIT's flagship bioengineering department offering BS, MS, and PhD programs with parallel synthetic biology, bioimaging, and translational research strengths. Closest structural analog to Stanford BioE among peer institutions and direct competitor for top graduate students and faculty.
  • UC Berkeley Bioengineering: Joint department between Berkeley College of Engineering and School of Medicine with parallel synthetic biology and computational bioengineering research. Already co-hosts the Stanford-Berkeley-UCSF Next Generation Faculty Symposium and partners on multiple joint programs.
  • Arc Institute: Stanford-adjacent independent research institute with parallel faculty search efforts. Competes for the same pool of bioengineering talent and operates with overlapping synthetic biology and genomics research priorities.
  • Johns Hopkins Biomedical Engineering: One of the oldest and largest US biomedical engineering programs, jointly housed across engineering and medicine schools. Comparable in scale, translational funding, and medical-device innovation pipeline.
  • Duke Biomedical Engineering: Duke's Pratt School of Engineering BME department with parallel medical-school integration and translational focus. Competes for graduate students and federal research funding in adjacent therapeutic areas.
  • UCSF Bioengineering: UCSF bioengineering program with medical-school-anchored translational focus. Co-participates in joint faculty search initiatives with Stanford and recruits from overlapping applicant pools.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Bioengineering department, Stanford University social profiles

Digital presence

Bioengineering department, Stanford University financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bioengineering department, Stanford University leadership team

Management profile

Number of profiles

Profiles5 records

Bioengineering department, Stanford University funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bioengineering department, Stanford University M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioengineering department, Stanford University

What does Bioengineering department, Stanford University do?

Stanford Bioengineering is an interdisciplinary academic department jointly housed between the Stanford School of Engineering and School of Medicine, offering undergraduate, coterminal, master's, PhD, and MD-affiliated degree programs alongside postdoctoral training. The department operates 30+ faculty-led research labs producing technologies in synthetic biology, CRISPR gene editing, AI-driven proteomics, bioimaging, cell-free protein synthesis, 3D bioprinting, and sustainable food systems. Outputs include commercialized open-source tools (Foldscope 2.0, The Squid), translational research via Stanford Biodesign, and community biology initiatives (LABraries, Foldscope distribution).

Is Bioengineering department, Stanford University a public or private company?

Bioengineering department, Stanford University is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Bioengineering department, Stanford University founded?

Bioengineering department, Stanford University was founded in 2002. It employs 1 to 10 people.

Where is Bioengineering department, Stanford University based?

Bioengineering department, Stanford University is headquartered in Stanford, United States, in the North America region.

How does Bioengineering department, Stanford University make money?

Five revenue lines are on record. Academic Tuition and Fees are the primary driver. The others are sponsored Research and Grants, licensing and Technology Transfer, gifts and Philanthropic Donations and executive Education and Professional Programs.

Who are Bioengineering department, Stanford University's main competitors?

Direct peers on record are Caltech Bioengineering, Wyss Institute for Biologically Inspired Engineering, Georgia Tech / Emory Biomedical Engineering, Chan Zuckerberg Biohub, MIT Department of Biological Engineering, UC Berkeley Bioengineering, Arc Institute, Johns Hopkins Biomedical Engineering, Duke Biomedical Engineering and UCSF Bioengineering.

Does Bioengineering department, Stanford University have an API?

No public API is recorded for Bioengineering department, Stanford University.

What industry is Bioengineering department, Stanford University in?

Bioengineering department, Stanford University's product category is Higher Education - Bioengineering Research and Training. Its primary akta.pro industry code is HLAAAIAD, Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development), with a secondary code of HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
WikipediaHwayoung Shon: Difference between revisionsThe article provides a biographical overview of Hwayoung Shon, detailing her career as a gayageum soloist and collaborative musician. It lists her international performances with various orchestras and ensembles, including collaborations at Stanford University and the Santa Cruz Symphony. The text also highlights specific events such as the world premiere of 'Night Owls' in 2024 and participation in cultural exhibitions in 2025.EXPANSIONLa IA crea los primeros virus sintéticosResearchers at Stanford University have developed an AI program named Evo 2 capable of generating synthetic viral genomes, successfully creating 16 new bacteriophages that proved more effective than natural models against E. coli. This breakthrough in generative biology aims to advance phage therapy as an alternative to antibiotics for drug-resistant bacteria, though it raises biosecurity concerns regarding potential misuse. The academic team states there are no immediate commercialization plans, emphasizing the need for robust governance frameworks to manage the technology's dual-use risks.Deccan HeraldScientists use AI to design synthetic viruses for the first timeScientists from Stanford University and the Arc Institute used an AI program called Evo to design synthetic viral genomes that are different from known viruses, targeting specific hosts. They generated and tested thousands of genome combinations, finding 16 viable viruses in the lab. This marks a pioneering effort in synthetic virus creation using AI.NaturalNewsBlogsScientists Report: AI Creates Never-Before-Seen Virus – NaturalNews.comResearchers at the Arc Institute in Palo Alto, California and Stanford University used an AI model called Evo to generate nearly 300 genomes of Phi X-174, a bacteriophage virus not found in nature, with 16 determined viable and some multiplying faster than the original in petri dish tests. The study, described by outside experts as a significant turning point in AI-designed biology, has raised urgent biosafety and biosecurity concerns, with Johns Hopkins researchers warning that the methods could potentially be adapted to design more dangerous pathogens. The researchers emphasized the resulting bacteriophages pose no threat to humans, but the article highlights ongoing policy debates about oversight of AI-generated biological sequences.DebugliesDe Novo Synthetic Genomes: Evo Genomic AI & Phage DesignResearchers at Stanford University and the Arc Institute used generative biological foundation models (Evo 1 and Evo 2) to design complete functional bacteriophage genomes from scratch, synthesizing 300 AI-generated sequences in the laboratory and achieving 16 fully viable, self-replicating phages that successfully lysed target Escherichia coli strains. Select AI-designed bacteriophages demonstrated bactericidal efficacy and lytic velocity exceeding naturally occurring wild-type ancestral isolates, proving that deep generative models can synthesize complete organisms by balancing complex multi-gene regulatory logic and structural assembly dynamics. The breakthrough exposes significant vulnerabilities in traditional homology-based DNA synthesis screening systems, which rely on sequence alignment against cataloged threat pathogens and fail to detect novel functional sequences generated by AI models that share minimal primary sequence identity with known agents.KXAN AustinAI could create viruses to combat drug-resistant bacteria, study showsStanford University researchers used generative AI models trained on millions of genomes to design bacteriophages with novel genomes capable of killing drug-resistant bacteria, synthesizing and testing nearly 300 designs to produce 16 viable phages. The AI-designed phages successfully overcame bacterial resistance that natural bacteriophages could not, demonstrating a major advance in synthetic biology with potential applications against deadly pathogens. The technology's ability to design entire functional viral genomes raises biosecurity concerns and complicates federal oversight of high-risk biological research.Tech TimesClaude Fable 5 Opens Biology for Clinicians: Researchers Wait on Broken PromiseAnthropic on August 7 announced it has reduced Claude Fable 5's biology fallback rate by approximately 85 percent, allowing everyday health users direct access to frontier reasoning for routine queries like blood test interpretation and clinical support, while professional researchers in virology, toxicology, and drug development remain blocked with no timeline for a promised trusted-access pathway originally expected within weeks of the June 9 launch. The update arrived one day after Stanford University and the Arc Institute published peer-reviewed research in Science showing that genome language models Evo 1 and Evo 2 designed functional viral genomes without requiring Fable 5, raising questions about whether Anthropic's classifier—which is a policy restriction rather than a technical barrier—addresses broader AI biosecurity governance gaps.San Francisco GateStanford AI virus study raises specter of bioweapon riskResearchers at Stanford University and the Arc Institute used an AI model to create viruses not found in nature, publishing their findings in Science. The study demonstrates AI's ability to generate virological data, which could advance disease research but raises biosafety concerns. safeguards were implemented, but experts warn of potential misuse for bioweapons.International Business TimesAI Is Now Designing Viruses From Scratch. Experts Say The Rules Aren’t ReadyScientists at Stanford University used a genome language model to design synthetic bacteriophages that have never existed in nature, synthesizing hundreds of AI-generated genome designs in the laboratory where 16 successfully infected and destroyed E. coli bacteria — marking the first time generative AI has designed complete viral genomes that function as living biological systems. The research demonstrates that AI can generate entirely new functional genomes rather than simply modifying existing organisms, with potential applications for phage therapies against antibiotic-resistant bacterial infections. Biosecurity experts at Johns Hopkins University argue that the technological capability has outpaced governance frameworks, and existing federal policies on high-risk life sciences research do not specifically address AI-generated biological designs.ExameEssa IA criou o genoma de um vírus não encontrado na natureza pela 1ª vez — e ele funcionouResearchers at Stanford University used a genomic AI model called Evo to design and synthesize functional bacteriophage genomes from scratch for the first time, successfully creating 16 viable viruses from approximately 300 synthesized candidates. The synthetic viruses demonstrated functional capability, with some outperforming the natural ΦX174 virus in bacterial infection tests and collectively overcoming antibiotic-resistant E. coli strains, showcasing potential for phage therapy against drug-resistant bacteria. Security experts from Johns Hopkins University published a commentary warning that no legal safeguards or detection tools currently exist to oversee AI-generated viral genomes, and the researchers have filed a provisional patent while making the Evo 2 model freely available.